TrialRain: Longitudinal Raincloud Panels for Clinical Endpoint Reporting
A reporting tool for pharma teams that tracks each patient's raw health data across multiple clinic visits.
A reporting add-on for pharma statistics teams that turns any repeated-measures clinical endpoint into a single figure showing every patient's raw data, group summaries, and distributions per visit — with each patient's scores linked across time — replacing tables of averages that hide how individual patients actually responded.
Concept
Clinical study reports and journal articles summarize repeated-measures endpoints (pain scores, patient-reported outcomes, lab values across visits) with means and confidence intervals — displays that hide per-patient variability, outliers, and the heterogeneous responses that often decide a trial's story. TrialRain is a reporting module built on the deployed ggrain package: point it at a long-format endpoint dataset (subject ID, visit, treatment arm, value) and it emits one publication-ready raincloud panel per endpoint. Each panel shows, per visit and per arm: raw dots for every patient (sample size and outliers visible at a glance), a box plot for median/IQR, and a violin for distribution shape — with each subject's observations connected across visit columns so intra-individual change is legible. Treatment arms are handled as factorial groups, and a continuous covariate such as baseline severity can be mapped into the display. Output is PDF/SVG through the Quarto/rmarkdown toolchain that pharma R teams already run, so figures drop directly into clinical study reports, posters, and submissions.
Why now
The enabling primitive is deployed, not a lab demo: ggrain is available on CRAN and GitHub, and its single geom_rain function already supports exactly what this needs — combining the three plot types (dots, box, violin), factorial grouping for treatment arms, mapping a secondary continuous covariate, and visualizing intra-individual change and variability across multiple waves, which is precisely the structure of repeated-measures clinical endpoints. Corpus evidence [5] (an interview study with 18 professional statisticians averaging 19.7 years in the profession) shows statisticians are prolific, early adopters of visualization in their analytic and reporting practice, so the required behavior change is minimal. The remaining work is a thin domain wrapper — mapping ADaM-style long data onto the geom and conforming to clinical study report figure standards — not new rendering science.
Written by GLM · 11 Oct 2026
AI assessment
A highly focused, low-risk tool that leverages an existing R package to solve a specific, high-value pain point in clinical trial reporting.
- Evidence strength 5/5
- The idea relies on a fully deployed CRAN package (ggrain) that explicitly supports longitudinal data and factorial grouping, corroborated by a study confirming statisticians' high adoption of specialized visualizations.
- Market pull 4/5
- Pharma statistics teams have a strong incentive to move beyond 'averages' to identify responders and outliers, though the buyer is likely the CRO or internal pharma team rather than the FDA/BMJ themselves.
- Novelty & moat 3/5
- While raincloud plots exist, applying them specifically as a standardized 'reporting add-on' for ADaM-style clinical data fills a gap between generic plotting and rigid clinical reporting.
- Feasibility 5/5
- The core rendering engine is already built; the MVP only requires a domain-specific wrapper to map clinical data formats to the existing geom_rain function.
- Wedge clarity 5/5
- The wedge is extremely sharp: replacing the 'table of means' in Clinical Study Reports with a single, publication-ready longitudinal raincloud panel.
- Simplicity / focus 5/5
- The product is a single-purpose reporting module with a clear input (long-format data) and output (PDF/SVG figure), avoiding platform creep.
Scored by Gemma 4 · 11 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Rochecompany
Roche's biostatistics groups produce clinical study reports across one of the industry's largest trial portfolios; per-patient transparent endpoint panels built on the R/ggplot2 stack they already use would surface heterogeneous responses to internal and regulatory reviewers without new tooling.
- IQVIAcompany
As a leading CRO, IQVIA delivers tables, listings, and figures for many sponsors; a repeatable longitudinal raincloud endpoint module differentiates its statistical reporting deliverables and cuts one-off figure work.
- FDAorganization
Reviewers assessing efficacy endpoints routinely request underlying data when summary figures are opaque; raincloud panels that expose sample size, outliers, and individual trajectories reduce that back-and-forth.
- Positcompany
Posit's Quarto/Connect reporting stack is standard in pharma R shops; a validated longitudinal raincloud report template increases the value of its commercial reporting products for clinical customers.
- The BMJcompany
The BMJ's editorial guidance favors transparent data display in figures; an easy pipeline for raw-data endpoint figures raises the quality of what authors submit.
Research it builds on
- Visualization According to Statisticians: An Interview Study on the Role of Visualization for Inferential StatisticsEric Newburger, Niklas Elmqvist · 2023 · 7 citationsAll ideas from this paper →
- ggrain – a R package for raincloud plotsNicholas Judd, Jordy van Langen, Davide Poggiali et al. · 2024 · 1 citationsAll ideas from this paper →